Fact based stock research
Hill-Rom (NYSE:HRC)


Hill-Rom stock research in summary

hill-rom.com


Hill-Rom shares have a BUY rating. They are good value and show above average growth, but are riskily financed. We recommend buying and holding Hill-Rom shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Equipment
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Large

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: Hill-Rom

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
78
89
80
88
STOCK GROWTH RANKS
56
92
68
57
STOCK SAFETY RANKS
36
36
7
41
COMBINED STOCK RANKS
47
97
27
71

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Hill-Rom in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Hill-Rom; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
74
64
43
45
PROFIT GROWTH
19
19
19
60
STOCK RETURNS
41
78
84
67
CONSOLIDATED RANK: GROWTH
56
92
68
57

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Hill-Rom.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
4
4
10
10
REFINANCING
85
80
73
66
LIQUIDITY
41
44
41
53
CONSOLIDATED RANK: SAFETY
36
36
7
41

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Hill-Rom and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Hill-Rom from June 8, 2018.